Papers
1
Total Citations
27
H-Index
1
About
Dr. Jeri Kim is a leading urologic oncologist whose research focuses on optimizing treatment outcomes and quality of life for men with prostate cancer. Her major contributions center on comparative effectiveness research, particularly evaluating functional and patient-reported outcomes following different treatment modalities. In her highly cited 2017 prospective cohort study, Dr. Kim provided critical comparative data on quality of life after brachytherapy versus bilateral nerve-sparing robot-assisted radical prostatectomy, helping patients make more informed treatment decisions. This work, with 27 citations, exemplifies her commitment to patient-centered research that directly impacts clinical practice. Dr. Kim's investigations into non-metastatic prostate cancer have advanced understanding of how treatment choices affect urinary, sexual, and bowel function, as well as overall well-being. Her research bridges the gap between surgical and radiation oncology, providing evidence that empowers patients and clinicians to weigh the trade-offs between cancer control and quality of life. Through her rigorous prospective studies, Dr. Kim has established herself as a key voice in personalized prostate cancer care, demonstrating that the best treatment is one that aligns with each patient's values and priorities.
Research Focus
Key Achievements
Top Papers
- 1